Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Minerva Neurosciences

Minerva Neurosciences reported $-5348520 in EBIT for its fiscal quarter ending in March of 2023.

Ebit Change
Acadia Pharmaceuticals ACAD:US USD -53584000 7.52M
ALKERMES ALKS:US USD -47494000 26.91M
AstraZeneca AZN:LN USD 2.78B 943M
BioCryst Pharmaceuticals BCRX:US USD -28415000 17.9M
Bristol-Myers Squibb BMY:US USD 3B 686M
Eli Lilly LLY:US USD 1.6B 515.6M
Esperion Therapeutics ESPR:US USD -48605000 6.09M
GlaxoSmithKline GSK:LN GBP 1.92B 483M
Halozyme Therapeutics HALO:US USD 53.8M 22.11M
Ionis Pharmaceuticals IONS:US USD -114148000 93.87M
J&J JNJ:US USD 7.12B 826.8M
Marinus Pharmaceuticals MRNS:US USD -32963000 3.75M
Merck & Co MRK:US USD 4.41B 1.14B
Minerva Neurosciences NERV:US USD -5348520 278.79K
Neurocrine Biosciences NBIX:US USD 29.7M 73.7M
Novartis NOVN:VX USD 3.23B 123M
Novavax NVAX:US USD -312768000 68.89M
Pfizer PFE:US USD 6.91B 1.1B
Roche Holding ROG:VX CHF 8.49B 3.05B
Takeda 4502:JP JPY 88.56B 73.33B